Literature DB >> 6281026

Human monoclonal autoimmune antibody produced in vitro: rheumatoid factor generated by Epstein-Barr virus-transformed cell line.

M Steinitz, S Tamir.   

Abstract

The infection of selected lymphocytes from a rheumatoid arthritis patient with Epstein-Barr virus resulted in an immortalized cell line that secretes a monoclonal rheumatoid factor (RF). The cloned line has been growing for more than 24 months, and constantly produces a monoclonal IgM, lambda, 19S, RF (1-2 micrograms/ml/106 cells). The RF agglutinates human and rabbit IgG (but not IgM) and also protein A-coated erythrocytes, but fails to do so to mouse, goat and swine IgG-coated erythrocytes. When bound to immune complexes, this monoclonal RF dose not bind complement. In the cell supernatant RF is the only immunoglobulin and it comprises approximately 5% of the total proteins. The affinity of RF to aggregated human IgG, as detected in inhibition experiments, is higher than that of Fc receptors found on human non-T lymphocytes, K562 and Daudi cell lines.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281026     DOI: 10.1002/eji.1830120206

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Requirements for the production of high-titre C3 nephritic factor (NEF) antibody in vitro.

Authors:  M A Marín; G Fontán; M López-Trascasa
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

2.  A human monoclonal IgA rheumatoid factor using the VkIV light chain gene.

Authors:  R Mierau; A Gause; R Küppers; M Michels; R A Mageed; R Jefferis; E Genth
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

3.  Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis.

Authors:  Jeremy Sokolove; Dannette S Johnson; Lauren J Lahey; Catriona A Wagner; Danye Cheng; Geoffrey M Thiele; Kaleb Michaud; Harlan Sayles; Andreas M Reimold; Liron Caplan; Grant W Cannon; Gail Kerr; Ted R Mikuls; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

Review 4.  B cell clones in rheumatoid arthritis.

Authors:  M Steinitz
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities.

Authors:  R F Tiebout; R W Sauerwein; W G van der Meer; F van Boxtel-Oosterhof; W P Zeijlemaker
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

6.  Generating human monoclonal antibodies.

Authors:  A M Neville; P A Edwards; M J O'Hare
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

7.  Crystallization of a complex between the Fab fragment of a human immunoglobulin M (IgM) rheumatoid factor (RF-AN) and the Fc fragment of human IgG4.

Authors:  M K Sohi; A L Corper; T Wan; M Steinitz; R Jefferis; D Beale; M He; A Feinstein; B J Sutton; M J Taussig
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

Review 8.  The use of the clinical immunology laboratory.

Authors:  S H Yoshida; B C Veit; L E Mansfield; M E Gershwin
Journal:  Clin Rev Allergy       Date:  1994

9.  Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice.

Authors:  A N Theofilopoulos; R S Balderas; L Hang; F J Dixon
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  Immortalization of human lymphocytes by fusion with cytoplasts of transformed mouse L cells.

Authors:  H Abken; H Jungfer; W H Albert; K Willecke
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.